AI Digital Bio Core

Mark your calendars! On May 28th, Aquillius and ThinkingNode.Life (TNL) are teaming up to unveil a groundbreaking partnership at the AIDBIO Core event. This collaboration brings together the power of Aquillius' expertise and TNL's industry-leading AI Digital Cell technology to accelerate drug discovery and development.

What is TNL?

Imagine testing new drugs on human cells – in just hours, not years! TNL's innovative platform utilizes AI to generate digital clones of human cells. These "digital cell clones" act like real cells, allowing scientists to predict and understand how drugs will interact with them before ever needing real people or animals.

Why is this a game-changer?

Here's how TNL can save you time, resources, and money:

• Faster Drug Testing: Reduce the time it takes to test new drugs by using digital cells instead of traditional methods.
• Reduced Costs: Eliminate the need for expensive and time-consuming animal testing.
• Improved Accuracy: Gain a deeper understanding of how drugs will affect human cells, leading to more effective treatments.
• Novel Target Discovery: Identify new targets for treating diseases, leading to breakthroughs in previously difficult areas.

Join us at AIDBIO Core on May 28th!

At our joint presentation, you'll learn more about how TNL's AI Digital Cell technology can revolutionize your drug discovery pipeline. We'll delve into:

• The science behind TNL and its advantages over traditional methods.
• Real-world examples of how TNL is being used to develop new drugs.
• How you can leverage TNL's capabilities to streamline your R&D process.

Don't miss this exciting opportunity to be at the forefront of the future of drug discovery!

Event Venue

10918 Technology Pl, 10918 Technology Place, San Diego, United States